100 related articles for article (PubMed ID: 1383624)
21. Early versus delayed angiotensin-converting enzyme inhibition in experimental chronic heart failure. Effects on survival, hemodynamics, and cardiovascular remodeling.
Mulder P; Devaux B; Richard V; Henry JP; Wimart MC; Thibout E; Macé B; Thuillez C
Circulation; 1997 Mar; 95(5):1314-9. PubMed ID: 9054865
[TBL] [Abstract][Full Text] [Related]
22. Trandolapril. An update of its pharmacology and therapeutic use in cardiovascular disorders.
Peters DC; Noble S; Plosker GL
Drugs; 1998 Nov; 56(5):871-93. PubMed ID: 9829159
[TBL] [Abstract][Full Text] [Related]
23. Early neurohormonal effects of trandolapril in patients with left ventricular dysfunction and a recent acute myocardial infarction: a double-blind, randomized, placebo-controlled multicentre study.
Sigurdsson A; Eriksson SV; Hall C; Kahan T; Swedberg K
Eur J Heart Fail; 2001 Jan; 3(1):69-78. PubMed ID: 11163738
[TBL] [Abstract][Full Text] [Related]
24. Effects of ACE inhibitor and AT1 blocker on dystrophin-related proteins and calpain in failing heart.
Takahashi M; Tanonaka K; Yoshida H; Oikawa R; Koshimizu M; Daicho T; Toyo-Oka T; Takeo S
Cardiovasc Res; 2005 Feb; 65(2):356-65. PubMed ID: 15639474
[TBL] [Abstract][Full Text] [Related]
25. Effects of angiotensin I-converting enzyme inhibitor and angiotensin II type 1 receptor blocker on the right ventricular sarcoglycans and dystrophin after left coronary artery ligation.
Takahashi M; Tanonaka K; Yoshida H; Koshimizu M; Oikawa R; Daicho T; Takeo S
Eur J Pharmacol; 2005 Oct; 522(1-3):84-93. PubMed ID: 16185685
[TBL] [Abstract][Full Text] [Related]
26. Effects of trandolapril on cardiac angiotensin I converting enzyme activity in rats with chronic heart failure following myocardial infarction.
Sanbe A; Tsukada J; Takeo S
Jpn Heart J; 1995 Jul; 36(4):451-63. PubMed ID: 7474361
[TBL] [Abstract][Full Text] [Related]
27. Long-term effects of the endothelin(A) receptor antagonist LU 135252 and the angiotensin-converting enzyme inhibitor trandolapril on diabetic angiopathy and nephropathy in a chronic type I diabetes mellitus rat model.
Dhein S; Hochreuther S; Aus Dem Spring C; Bollig K; Hufnagel C; Raschack M
J Pharmacol Exp Ther; 2000 May; 293(2):351-9. PubMed ID: 10773002
[TBL] [Abstract][Full Text] [Related]
28. Effect of ACE inhibitor trandolapril on life expectancy of patients with reduced left-ventricular function after acute myocardial infarction. TRACE Study Group. Trandolapril Cardiac Evaluation.
Torp-Pedersen C; Køber L
Lancet; 1999 Jul; 354(9172):9-12. PubMed ID: 10406358
[TBL] [Abstract][Full Text] [Related]
29. Enalapril improves arterial elastic properties in rats with myocardial infarction.
Ben Driss A; Himbert C; Poitevin P; Duriez M; Michel JB; Levy BI
J Cardiovasc Pharmacol; 1999 Jul; 34(1):102-7. PubMed ID: 10413075
[TBL] [Abstract][Full Text] [Related]
30. Treatment with verapamil and trandolapril in patients with congestive heart failure and angina pectoris or myocardial infarction. The DAVIT Study Group. Danish Verapamil Infarction Trial.
Hansen JF; Hagerup L; Sigurd B; Pedersen F; Mellemgaard K; Bjergaard OP
Am Heart J; 1997 Aug; 134(2 Pt 2):S48-52. PubMed ID: 9313623
[TBL] [Abstract][Full Text] [Related]
31. Dosing time-dependent effect of trandolapril on the prevention of cardiac hypertrophy in rats with aortic banding.
Sugimoto K; Ohmori M; Kawaguchi A; Tsuruoka S; Fujimura A
Jpn J Pharmacol; 2001 Sep; 87(1):86-9. PubMed ID: 11676204
[TBL] [Abstract][Full Text] [Related]
32. Cardiac event rates after acute myocardial infarction in patients treated with verapamil and trandolapril versus trandolapril alone. Danish Verapamil Infarction Trial (DAVIT) Study Group.
Hansen JF; Hagerup L; Sigurd B; Pedersen F; Mellemgaard K; Pedersen-Bjergaard O; Mortensen LS
Am J Cardiol; 1997 Mar; 79(6):738-41. PubMed ID: 9070551
[TBL] [Abstract][Full Text] [Related]
33. Angiotensin-converting enzyme inhibition after myocardial infarction: the Trandolapril Cardiac Evaluation Study.
Torp-Pedersen C; Køber L; Carlsen J
Am Heart J; 1996 Jul; 132(1 Pt 2 Su):235-43. PubMed ID: 8677862
[TBL] [Abstract][Full Text] [Related]
34. Treatment with verapamil and trandolapril in patients with congestive heart failure and myocardial infarction. The Danish Verapamil Infarction Trial (DAVIT Study Group).
Hansen JF; Hagerup L; Sigurd B; Pedersen F; Mellemgaard K; Pedersen-Bjergaard O
J Hypertens Suppl; 1997 Mar; 15(2):S119-22. PubMed ID: 9218208
[TBL] [Abstract][Full Text] [Related]
35. [The effect of perindoprilat on the cardiovascular system of rats with heart failure].
Gorodetskaia EA; Allabergenova EA; Moleva EB; Medvedev OS
Eksp Klin Farmakol; 1994; 57(1):27-9. PubMed ID: 8142858
[TBL] [Abstract][Full Text] [Related]
36. Digitoxin prolongs survival of female rats with heart failure due to large myocardial infarction.
Helber I; Dos Santos AA; Antonio EL; Flumignan RL; Bocalini DS; Piccolo C; Gheorghiade M; Tucci PJ
J Card Fail; 2009 Nov; 15(9):798-804. PubMed ID: 19879467
[TBL] [Abstract][Full Text] [Related]
37. Trandolapril in left ventricular dysfunction after myocardial infarction: focus on the TRACE study.
Coca A; Rabasseda X
Drugs Today (Barc); 2003 Jan; 39(1):5-18. PubMed ID: 12669106
[TBL] [Abstract][Full Text] [Related]
38. Progressive left ventricular hypertrophy after withdrawal of long-term ACE inhibition following experimental myocardial infarction.
Westendorp B; Schoemaker RG; Buikema H; Boomsma F; van Veldhuisen DJ; van Gilst WH
Eur J Heart Fail; 2006 Mar; 8(2):122-30. PubMed ID: 16084760
[TBL] [Abstract][Full Text] [Related]
39. Trandolapril in patients with left ventricular dysfunction after myocardial infarction.
Neumayr G; Gänzer J
N Engl J Med; 1996 Jun; 334(23):1546. PubMed ID: 8618619
[No Abstract] [Full Text] [Related]
40. Angiotensin-converting enzyme inhibition and salt in experimental myocardial infarction.
Yoshida K; Kohzuki M; Casley DJ; Johnston CI
J Cardiovasc Pharmacol; 1998 Sep; 32(3):357-65. PubMed ID: 9733347
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
